We are thrilled to announce that Dr. Vesna Kostanjevecki has joined 4Tissue as our new Head of Clinical and Regulatory Affairs. As we prepare for the first clinical studies of our innovative hydrogel technology, Dr. Kostanjevecki's appointment is a key step in strengthening our capacity to successfully navigate the regulatory and quality control...
We are thrilled to congratulate An Van Den Bulcke, our co-founder and Chief Business Officer, on her selection for the prestigious EIC Women Leadership Programme, Cohort 8!
For International Women's Day, Invest in Ghent spoke with our very own An Van Den Bulcke and Sandra Van Vlierberghe about the groundbreaking work we're doing at 4Tissue in breast reconstruction using our hydrogel technology.
Ghent, February 26, 2025 — 4Tissue, a pioneer in biotechnology that is revolutionizing regenerative medicine, has successfully completed an additional €1.5M funding round, consisting of €1M in equity investments and additional grants. This funding will support the further development of the company's groundbreaking bioresorbable hydrogel...
On the International Day of Women and Girls in Science, we celebrate the groundbreaking contributions of women in science and technology, inspiring future generations to follow in their footsteps. This spirit of empowerment is embodied by us, 4Tissue, a women-led company where leadership, innovation, and progress are driven by women for women.
3D printing, once considered a niche technology, has quickly become a transformative force in regenerative medicine. Its growing application in tissue engineering is reshaping how we approach the regeneration and repair of human tissues—moving beyond simple structures to the creation of more complex biological systems. But where is 3D printing...
An Van Den Bulcke (COO) and Lana Van Damme (CSO) applied for the Women TechEU programme, which received 827 applications from 41 countries, highlighting the increasing demand for support in women-led startups to foster a more gender-balanced entrepreneurship ecosystem.
4Tissue's latest article has been featured in the 24th edition of BiotechNews & Life Sciences magazine!
On page 56 you can read all about the recent €2 million seed funding and how it will drive the development of a cutting-edge hydrogel technology for breast reconstruction.
At 4Tissue, we are passionate about advancing regenerative medicine and...
At 4Tissue, we believe in the power of innovation to transform lives. Our journey began with a critical question: How can we create a truly natural, long-lasting solution for breast reconstruction that uses the body's own materials? This challenge brought together a team of experts from diverse fields—each with a deep commitment to women's health...
In this feature, we dive into how we've secured €2 million to fast-track the development of our revolutionary injectable breast implants.
Curious how it works? Our unique gel acts like a backpack, providing the necessary fuel and protection to naturally regenerate new, healthy tissue.
